Last reviewed · How we verify
NCT05784948
Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis
NA trial testing Virtual Reality Mindfulness Treatment in Schizophrenia Spectrum Disorders in 67 participants. Completed in 9 June 2021.
9 June 2021
Quick facts
| Lead sponsor | Chonbuk National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 67 |
| Start date | 8 April 2020 |
| Primary completion | 9 June 2021 |
| Estimated completion | 9 June 2021 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Virtual Reality Mindfulness Treatment
- Experience relaxing scenery and music
Conditions studied
- Schizophrenia Spectrum Disorders — all drugs for Schizophrenia Spectrum Disorders →
- Schizophrenia — all drugs for Schizophrenia →
- Schizoaffective Disorder — all drugs for Schizoaffective Disorder →
- Schizophreniform Disorders — all drugs for Schizophreniform Disorders →
Sponsor
Chonbuk National University Hospital
Who can join
Adults 15 to 59, any sex, with Schizophrenia Spectrum Disorders or Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to evaluate the safety and efficacy of Virtual Reality Mindfulness in Patients With Psychosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05784948
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia Spectrum Disorders
Currently open trials in the same condition.
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT06138054 — MI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMI · NA · recruiting
- NCT05945602 — Neurophysiologic Biomarkers for Cognitive Rehabilitation · recruiting
Other Chonbuk National University Hospital trials
Trials by the same sponsor.
- NCT05324800 — the Efficacy and Safety of Curcuma Longa Extract Mixture on Immune Enhancement · NA · unknown
- NCT05450939 — Characteristics of Signal Intensity Gradient in Subarachnoid Hemorrhage After Aneurysmal Rupture · unknown
- NCT05190237 — the Efficacy and Safety of Fermented Soybean(Doenjang Powder) on Intestinal Microflora and Immune Enhancement. · NA · completed
- NCT05495191 — Signal Intensity Gradient in Cerebral Arteries · completed
- NCT04940910 — The Efficacy and Safety of Black Rice Bran Extract on Immune Enhancement · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05784948 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chonbuk National University Hospital
- Last refreshed: 10 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05784948.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing